
Vertex Pharmaceuticals (VRTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Vertex Pharmaceuticals (VRTX) Stock
Start investing in Vertex Pharmaceuticals (VRTX)
About Vertex Pharmaceuticals (VRTX)
Market cap | $114.33B |
Yesterday's volume | 1.24M |
Revenue (TTM) | $11.04B |
Avg. daily volume | 1.74M |
EBITDA (TTM) | -$129.7M |
Open | $440.45 |
Price / earnings ratio | -113.50x |
Yesterday's range | $439.23 - $446.45 |
Debt / equity | 10x |
52 week range | $377.85 - $519.88 |
5 year debt / equity | 7.81x |
Beta (LTM) | 0.48x |
Interest coverage | 142.46x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 2.65x |
Ex-dividend date | — |
Next earnings | Jul 31, 2025 |
Dividend payable date | — |
Vertex Pharmaceuticals Stock Rating
Vertex Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy VRTX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in VRTX stock
Navigate to the Explore page. Then, type VRTX into the search bar. When you see VRTX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased VRTX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Vertex Pharmaceuticals Stock Earnings
The value each VRTX share was expected to gain vs. the value that each VRTX share actually gained.
Vertex Pharmaceuticals (VRTX) reported Q1 2025 earnings per share (EPS) of $4.06, missing estimates of $4.29 by 5.36%. In the same quarter last year, Vertex Pharmaceuticals's earnings per share (EPS) was $4.76. Vertex Pharmaceuticals is expected to release next earnings on 07/31/2025, with an earnings per share (EPS) estimate of $4.28.